“Our findings highlight the vital importance of seeking expert opinions from National Cancer Institute-designated cancer centers, especially with rare blood and bone marrow cancers such as MDS,” said Dr. Mikkael Sekeres, chief of Hematology at Sylvester Comprehensive Cancer Center.